Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lonsurf 15mg/6.14mg tablets
0801030AFBBAAAA
|
Lonsurf | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
|
Lonsurf 20mg/8.19mg tablets
0801030AFBBABAB
|
Lonsurf | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
|
Trifluridine 15mg / Tipiracil 6.14mg tablets
0801030AFAAAAAA
|
Trifluridine/tipiracil | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
|
Trifluridine 20mg / Tipiracil 8.19mg tablets
0801030AFAAABAB
|
Trifluridine/tipiracil | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.